Hannu Ryopponen

Private Investor and NED

📍 United Kingdom, United Kingdom🔄 Updated September 2026💼 4 investments📅 17 years investing🗓 Last invested Mar 2019
Angel investor🌍 United Kingdom
4
Total investments
0
Early stage
0
Mid stage
0
Late stage
17y
Years active

Portfolio

0 investments · sorted by recency
All investments
Early stage
Mid stage
Late stage
No investments found
Experience · 4 entries
All (4)
Investments (4)
Board (4)
2019
LIG OY
Board Member, non-exec
Mar 2019
2009
Non Executive Board Member
Apr 2009
To thrive tomorrow, businesses must show meaningful sustainability and climate action today. Neste has done the hard work – we’re ready to help your business fight climate change and reduce greenhouse gas emissions now.
Non Executive Board Member
Mar 2009
We are a global group of iconic sports and outdoor brands, including Arcteryx, Salomon, Wilson, Peak Performance, Atomic, and Armada. Our purpose is to elevate the world through sport—from courts to slopes, from cities to mountains, and everywhere in between, we aim to inspire people to explore and experience the joy of sports and outdoor activities, and lead better, healthier lives. Our global community of 11,400 people operates in 41 countries. Amer Sports, Inc. shares are listed on the New York Stock Exchange. Join our global community in elevating the world through sport!
Non Executive Board Member
Mar 2009
We’re not your typical healthcare company. In a modern world of quick fixes, we focus on solutions to defeat serious chronic disease and create long-term health. Our unordinary mindset is at the heart of everything we do. We seek out new ideas and put people first as we push the boundaries of science, make healthcare more accessible, and work to treat, prevent, and even cure diseases that affect millions of lives. Founded in Denmark in 1923, today we employ more than 68,800 people in 80 offices around the world – all united by our bold purpose to drive change to defeat serious chronic diseases. Want to learn more? Visit www.novonordisk.com. This page isn’t intended for discussions about products. As such, postings or comments that contain product discussions may be removed. This page is for discussions about Novo Nordisk and its subsidiaries and the initiatives and projects we are involved in. While we welcome everyone to make comments, we reserve the right to block and remove those that are off-topic, abusive or intended to spam. Any questions specific to products should be made to your healthcare professional. If you wish to file an adverse drug reaction please contact Novo Nordisk’s office in the country you live in: https://www.novonordisk.com/contact-us/find-local-information.html For other customer complaints, please contact us here: https://www.novonordisk.com/contact-us.html Please keep in mind that Novo Nordisk A/S and its subsidiaries work within a highly regulated industry. Therefore, comments that pertain to legal matters or regulatory issues may be removed. Comments contained on this site come from members of the public, and do not necessarily reflect the views of Novo Nordisk A/S. Novo Nordisk A/S does not endorse or approve any content added by other LinkedIn users. Learn more about our privacy disclaimer and community guidelines here: https://www.novonordisk.com/data-privacy-and-user-rights/social-media-privacy-disclaimer.html
Investment activity
2009–2019 · 4 investments
2009320191
Recent (last 2 years)Earlier